DocWire News Editors

DocwireNews

E-cigarettes have become a popular tool for people looking to give up their smoking habit,&nbsp;but are they really the best way to help smokers overcome addiction?&nbsp;A study published today in&nbsp;The New England Journal of Medicine&nbsp;aimed to answer this question by seeing how effective different interventions are in promoting cessation of smoking.&nbsp;&nbsp;Using 6,006 subjects, researchers randomly assigned them to one of five groups. The&nbsp;usual care group received&nbsp;both motivational texts and&nbsp;information&nbsp;about&nbsp;the benefits associated with quitting&nbsp;cigarette use. Each of the other four groups received usual care in addition to one of the following: free cessation aids (nicotine replacement therapy with e-cigarettes if therapy failed), free e-cigarettes,&nbsp;free cessation aids with a $600 reward for continued cessation of smoking,&nbsp;or free cessation aids with $600 in redeemable funds (money removed if&nbsp;sequential&nbsp;cessation markers were not hit).&nbsp;The primary outcome was defined to be maintained cessation of smoking 6 months after the&nbsp;date of&nbsp;initial termination.&nbsp;Rates of sustained abstinence from smoking&nbsp;after&nbsp;6 months&nbsp;were found to be 0.1% in the usual care group, 0.5% in the free cessation aids group, 1.0% in the free e-cigarettes group, 2.0% in the free cessation plus rewards group, and 2.9% in the redeemable fund group.&nbsp;Regarding rates of sustained abstinence,&nbsp;redeemable deposits (P&lt;0.001) were found to be more effective than free cessation aids (P=0.006), and free e-cigarettes (P=0.008). Free cigarettes were not found to be more effective than&nbsp;usual care&nbsp;(P=0.20), or free cessation aids (P=0.43).&nbsp;&nbsp;Overall, these results showed&nbsp;that the addition of financial incentive to free cessation aids gave rise to higher sustained cessation rates, and that addition of free cessation aids or e-cigarettes to usual care did not provide a significant benefit.&nbsp;This calls into question the efficacy of e-cigarettes as a means of quitting smoking, and perhaps indicates a need for more reward-based intervention in the cessation of smoking.&nbsp;&nbsp;Source: NEJM&nbsp;

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

E-Cigarettes: Can They Help You Quit Smoking on Their Own?

Pulmonology

E-cigarettes have become a popular tool for people looking to give up their smoking habit, but are they really the best way to help smokers overcome addiction? A study ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe